miR-25802 orchestrates the KLF4/NF-κB pathway in microglia-mediated neuroinflammation, facilitating cognitive impairments and Aβ toxicity, highlighting the potential of targeting miR-25802 and its regulatory network as an emerging frontier in AD treatment. The gene discussed is KLF4; the disease is Cognitive impairment.